Eulerpool Terminal
The edge that pays for itself.
Current Zenas Biopharma forecasts and price targets in August 2026
Ø Analyst Price Targets
41.57 USD
+33.18 %
Median
45.39 USD
+45.43 %
Max
57.75 USD
Min
19.19 USD
Last Price
31.21 USD
Buy
12
Hold
2
Sell
0
The average target price for Zenas Biopharma is 41.57 USD. (+33.18 % above the current price)
The median price target of Zenas Biopharma is 45.39 USD.
Stock analysts from many renowned investment banks are closely examining the Zenas Biopharma stock. They conclude their professional Zenas Biopharma stock analyses with a clear recommendation for the Zenas Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 12 | 2 | 0 | 41.57 USD |
| 2026-01-01 | 13 | 1 | 0 | 41.57 USD |
| 2025-12-01 | 13 | 1 | 0 | 48.71 USD |
| 2025-12-01 | 13 | 1 | 0 | 45.90 USD |
| 2025-11-01 | 12 | 1 | 0 | 44.44 USD |
| 2025-11-01 | 12 | 1 | 0 | 40.22 USD |
Zenas Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Zenas Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 36.00 M USD | -230.00 M USD | -4.95 USD |
| 2027e | 63.00 M USD | -121.00 M USD | -2.60 USD |
| 2028e | 146.00 M USD | -222.00 M USD | -4.77 USD |